Heron Financial Statements From 2010 to 2026

Stocks USA . 
Stock . Heron Therapeuti
HRTX Stock  USD 1.21  0.00  0.00%   
Heron Therapeuti's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Heron Therapeuti's valuation are provided below:
Gross Profit
102.8 M
Profit Margin
(0.09)
Market Capitalization
231 M
Enterprise Value Revenue
2.0881
Revenue
155.1 M
We have found one hundred twenty available fundamental trends for Heron Therapeuti, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Heron Therapeuti regular market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 849.6 M in 2026. Enterprise Value is likely to rise to about 914.8 M in 2026

Heron Therapeuti Total Revenue

174.22 Million

Check Heron Therapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heron Therapeuti's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3 M, Interest Expense of 7.3 M or Total Revenue of 174.2 M, as well as many indicators such as Price To Sales Ratio of 1.38, Dividend Yield of 0.0 or Days Sales Outstanding of 109. Heron financial statements analysis is a perfect complement when working with Heron Therapeuti Valuation or Volatility modules.
  
Build AI portfolio with Heron Stock
Check out the analysis of Heron Therapeuti Correlation against competitors.
For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

Heron Therapeuti Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets281.5 M268.1 M210.5 M
Slightly volatile
Short and Long Term Debt Total214.6 M204.4 M72.5 M
Slightly volatile
Other Current Liabilities92.6 M88.2 M49.1 M
Slightly volatile
Total Current Liabilities110.4 M105.2 M60.1 M
Slightly volatile
Property Plant And Equipment Net21.3 M20.3 M15.4 M
Slightly volatile
Cash27.8 M29.7 M52.5 M
Very volatile
Non Current Assets Total29.1 M27.8 M19.3 M
Slightly volatile
Non Currrent Assets Other7.8 M7.5 M3.9 M
Slightly volatile
Cash And Short Term Investments61 M68.2 M119.4 M
Pretty Stable
Net Receivables95.2 M90.7 M35.5 M
Slightly volatile
Common Stock Shares Outstanding184.1 M175.3 M76.1 M
Slightly volatile
Liabilities And Stockholders Equity281.5 M268.1 M210.5 M
Slightly volatile
Other Stockholder Equity2.3 B2.2 B1.1 B
Slightly volatile
Total Liabilities322.2 M306.8 M128.2 M
Slightly volatile
Property Plant And Equipment Gross42.9 M40.8 M19.9 M
Slightly volatile
Total Current Assets252.4 M240.4 M191.3 M
Slightly volatile
Short Term Debt3.5 M3.5 M4.6 M
Pretty Stable
Other Current Assets21.4 M20.3 M10.8 M
Slightly volatile
Accounts Payable14.1 M13.5 M6.3 M
Slightly volatile
Common Stock Total Equity658 K1.2 M921.5 K
Very volatile
Common Stock1.8 M1.7 M1.1 M
Pretty Stable
Other Liabilities263.3 K277.1 K17.8 M
Slightly volatile
Other Assets19 M18.1 M7.1 M
Slightly volatile
Property Plant Equipment36 M34.3 M16.2 M
Slightly volatile
Current Deferred Revenue3.3 M3.2 M1.9 M
Slightly volatile
Capital Surpluse2 B1.9 B1.1 B
Slightly volatile
Short and Long Term Debt8.3 M8.1 M6.1 M
Slightly volatile
Long Term Debt Total109.5 M171.4 M107.3 M
Slightly volatile
Non Current Liabilities Other525.8 K553.5 K24.2 M
Slightly volatile
Net Invested Capital185.8 M127 M193.5 M
Very volatile
Net Working Capital160.7 M105.8 M161.6 M
Very volatile
Capital Stock1.2 M1.7 M1 M
Slightly volatile
Capital Lease Obligations2.6 M2.7 M11.3 M
Slightly volatile

Heron Therapeuti Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3 M2.9 M1.7 M
Slightly volatile
Other Operating Expenses188.1 M179.2 M173.4 M
Slightly volatile
Cost Of Revenue46.7 M44.4 M33.2 M
Slightly volatile
Total Operating Expenses73.5 M134.7 M144.3 M
Slightly volatile
Research Development18.2 M19.2 M72.6 M
Pretty Stable
Selling General Administrative64.5 M61.4 M33.6 M
Slightly volatile
Selling And Marketing Expenses62.7 M54.1 M45.8 M
Slightly volatile
Interest Income2.6 M3.2 M2.8 M
Pretty Stable
Reconciled Depreciation2.7 M2.9 M2.1 M
Slightly volatile

Heron Therapeuti Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow27.9 M33 M50.8 M
Pretty Stable
Depreciation3 M2.9 M1.7 M
Slightly volatile
Capital Expenditures1.8 M2 M2.8 M
Pretty Stable
Total Cash From Financing Activities1 M1.1 M90.1 M
Very volatile
End Period Cash Flow28.5 M29.7 M51.7 M
Very volatile
Stock Based Compensation24.1 M14.9 M24 M
Slightly volatile
Sale Purchase Of Stock7.7 M8.1 M71.2 M
Very volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.381.45116
Slightly volatile
Days Sales Outstanding109180326
Slightly volatile
Stock Based Compensation To Revenue0.09810.15.8717
Slightly volatile
Capex To Depreciation1.160.622.246
Slightly volatile
EV To Sales2.282.4116
Slightly volatile
Inventory Turnover0.790.840.7406
Slightly volatile
Days Of Inventory On Hand42945219.9 K
Slightly volatile
Payables Turnover2.822.9712.2071
Pretty Stable
Sales General And Administrative To Revenue0.320.335.3474
Slightly volatile
Average Inventory70.2 K73.9 K198.8 K
Slightly volatile
Research And Ddevelopement To Revenue0.09890.121.8377
Slightly volatile
Capex To Revenue0.01010.01060.7516
Slightly volatile
Cash Per Share0.420.4510.8532
Slightly volatile
Days Payables Outstanding94.5599.524.5 K
Pretty Stable
Intangibles To Total Assets0.0250.04980.0514
Very volatile
Current Ratio2.52.635.6916
Slightly volatile
Receivables Turnover2.02.11.5884
Slightly volatile
Capex Per Share0.01220.01290.3956
Slightly volatile
Revenue Per Share1.031.091.5404
Slightly volatile
Interest Debt Per Share1.321.392.4152
Slightly volatile
Debt To Assets0.720.690.3159
Slightly volatile
Graham Number205138134
Very volatile
Operating Cycle60063120.2 K
Slightly volatile
Days Of Payables Outstanding94.5599.524.5 K
Pretty Stable
Ebt Per Ebit0.741.060.9991
Very volatile
Long Term Debt To Capitalization1.171.111.1503
Pretty Stable
Total Debt To Capitalization1.171.110.5044
Slightly volatile
Quick Ratio1.861.965.3921
Slightly volatile
Net Income Per E B T0.911.10.9719
Pretty Stable
Cash Ratio0.310.323.9142
Slightly volatile
Days Of Inventory Outstanding42945219.9 K
Slightly volatile
Days Of Sales Outstanding109180326
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.241.07571.0692
Slightly volatile
Fixed Asset Turnover7.737.363.1684
Slightly volatile
Debt Ratio0.720.690.3159
Slightly volatile
Price Sales Ratio1.381.45116
Slightly volatile
Asset Turnover0.40.710.2381
Slightly volatile

Heron Therapeuti Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap849.6 M809.1 M872.8 M
Pretty Stable
Enterprise Value914.8 M871.2 M860.9 M
Slightly volatile

Heron Fundamental Market Drivers

Heron Upcoming Events

28th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Heron Therapeuti Financial Statements

Heron Therapeuti investors use historical fundamental indicators, such as Heron Therapeuti's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Heron Therapeuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue3.2 M3.3 M
Total Revenue165.9 M174.2 M
Cost Of Revenue44.4 M46.7 M
Stock Based Compensation To Revenue 0.10  0.10 
Sales General And Administrative To Revenue 0.33  0.32 
Research And Ddevelopement To Revenue 0.10  0.10 
Capex To Revenue 0.01  0.01 
Revenue Per Share 1.09  1.03 
Ebit Per Revenue(0.09)(0.10)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
JBLJabil Circuit
MRKMerck Company
AMGNAmgen Inc

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY